A Korean R&D institute focusing on ICT-Bio healthcare area is looking for global partners for its technology on rapid diagnosis kit cartridges for the application of undiluted whole blood in license agreement and others

TechnologyJužná KóreaTOKR20201103003
Offers
Summary: 
A Korean R&D institute specialised in technology on rapid diagnosis kit cartridges for the application of undiluted whole blood wishes to expand its overseas market through licensing, technical cooperation and commercial agreement with technical assistance. It is through the direct injection of the high volume of undiluted whole blood that this cartridge technology enables blood plasma to be extracted in real time without pretreatments. Any organisation in need of such technology can be partner.
Description: 
Today, the rapid diagnosis kit market has been growing and particularly, as a typical method of POCT (Point-of-care testing), rapid immunochromatography test kit has been widely used for detecting infectious diseases or pregnancy etc., and the saturated-looking market is still expanding. Additionally, since rapid kits enable the immediate action on disease or specific biomarkers to be taken, point-of-care in need of rapid kits has been in spotlight as the method to resolve regulatory and cost issues. However, applying undiluted whole blood into conventional rapid kits causes blood flow not to last and stop at the inlet because the general rapid kit cartridge inlet presses the sample pad making relatively strong contact with the sample pad. In other words, blood contains a large amount of blood cells, so the sample inlet tends to be blocked by the accumulated blood cells. Thus, whole blood should be applied to conventional rapid kit after the pre-treatment such as centrifugation. Sometimes, diluted blood is applied only if the target marker exists in high amount enough to be detected even after huge dilution. The Korean R&D institute has devised plastic cartridges for rapid kits of which the inlet structure enables the cartridges to be applied to whole blood without pre-treatments such as dilution or lysis. Its inclined structure creates a blood island at the beginning of rapid kits from which plasma could be continuously supplied. In addition, multichannel rapid kits with the controlled flow has been also developed based on fluidics simulations. The selective and differential flow is able to be obtained by forming a hole in the filtering area which functioned as fluidic hurdle. In doing so, the new type of rapid kits detects specific material from undiluted whole blood. This new cartridge is designed to maintain the format and the configuration of membrane strips mounted on the existing kits, allowing to be immediately applicable to existing commercialized rapid kits with minimal modification. It means that potential partner is able to not only access the market immediately but reduce the risk of new product development. In particular, this technology is highly suitable for diagnostic items aiming at quickly detecting the small amount of substances from undiluted whole blood, thereby having comparative advantages. This is because there is no case yet to implement in-plane blood pre-treatment techniques without relying on an equipment, compared to existing rapid kit. Thus, companies wanting to enhance the sensitivity, speed of diagnosis, increase the market share in rapid kit industry or having difficulties of processing pre-treatment of whole blood can be the main partners. The Korean R&D institute who developed rapid diagnosis kit cartridges for the application of undiluted whole blood is now looking for global partners under license agreement, technical cooperation and commercial agreement with technical assistance.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought: 
- Type of partner sought : Companies, public institutions, private institutions hoping for enhancing the sensitivity and speed of diagnosis, increase the market share in rapid kit industry or having difficulties of processing pre-treatment of whole blood etc - Specific area of activity of the partner : any companies and institutions in need of rapid diagnosis kit cartridges technology for the application of undiluted whole blood - Task to be performed : Technology transfer, R&D cooperation or technology cooperation for new product development, licencing
Stage of Development: 
Prototype available for demonstration
IPR Status: 
Secret Know-how,Patents granted
Comments Regarding IPR Status: 
Diagnosis Kit / 2018 / South Korea
External code: 
TOKR20201103003